483Mar 19, 2020

483 Document: Surmasis Pharmaceutical


FDANews 483 Surmasis Pharmaceutical Mar 19 2020 top
Michele L. Glendenning FDA Investigator Peng Zhou FDA Investigator

On Mar 19, 2020, the FDA inspected Surmasis Pharmaceutical's Des Moines site. Explore the inspectional observations.